News search
 Research 21 Jun 2023 A new CNIC study shows that low-grade systemic inflammation triggered by subcinical atherosclerosis accelerates epigenetic aging in otherwise healthy young individuals |
 Research 29 May 2023 The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer |
 Research 21 May 2023 The team led by Dr. Pablo García-Pavía, based at the CNIC and Hospital Puerta de Hierro, has published the first study of a drug able to remove amyloid deposits from the heart |
 Research 6 Mar 2023 A study could change management of patients who are not critically ill |
 Research 3 Feb 2023 The discovery, published in the journal Immunity, identifies a new therapeutic route for conditions associated with obesity and metabolic syndrome, including cardiovascular disease |
 Research 16 Jan 2023 Nature Cardiovascular Research: The 'guardian of the genome' protects against cardiovascular disease A CNIC study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor |
 Research 12 Dec 2022 The results of the SPHERE-HF study are published in the European Journal of Heart Failure. SPHERE-HF is a multicenter academic clinical trial led by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital Clínic de Barcelona |
 Research 3 Nov 2022 CNIC scientists have identified a molecular mechanism that accounts for the arrhythmias, skeletal muscle weakness, and periodic paralysis in patients with this rare disease |
 About the CNIC 2 Nov 2022 A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor |
 |
- ‹ previous
- 3 of 26
- next ›
